We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.98%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$543M
AUM Growth
-$13.1M
(-2.4%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
68.19%
Holding
65
New
6
Increased
25
Reduced
15
Closed
8
Top Buys
| 1 |
Iris Energy
IREN
|
+$7.74M |
| 2 |
Lemonade
LMND
|
+$6.94M |
| 3 |
Viridian Therapeutics
VRDN
|
+$4.76M |
| 4 |
Biogen
BIIB
|
+$3.52M |
| 5 |
enGene Therapeutics
ENGN
|
+$2.82M |
Top Sells
| 1 |
Spotify
SPOT
|
+$16.9M |
| 2 |
Tesla
TSLA
|
+$6.87M |
| 3 |
Amazon
AMZN
|
+$6.41M |
| 4 |
Arrowhead Research
ARWR
|
+$3.71M |
| 5 |
Sea Limited
SE
|
+$3.26M |
Sector Composition
| 1 | Healthcare | 29.46% |
| 2 | Consumer Discretionary | 27.3% |
| 3 | Technology | 25.78% |
| 4 | Financials | 8.49% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
enGene Therapeutics
ENGN
$127M
| $3.18M | 0.59% |
+352,087
| New | +$2.82M |
|
27
BioNTech
BNTX
$22.9B
| $3.17M | 0.58% |
33,300
+14,300
| +75% | +$1.44M |
|
28
Krystal Biotech
KRYS
$10B
| $3M | 0.55% |
12,170
| – | – |
|
29
Ambev
ABEV
$47.7B
| $2.63M | 0.48% |
1,063,174
+166,040
| +19% | +$395K |
|
30
Zai Lab
ZLAB
$2.18B
| $2.33M | 0.43% |
132,189
| – | – |
|
31
CRISPR Therapeutics
CRSP
$4.97B
| $2.25M | 0.41% |
42,874
+2,874
| +7% | +$172K |
|
32
Beam Therapeutics
BEAM
$3.18B
| $1.98M | 0.36% |
71,500
+10,500
| +17% | +$268K |
|
33
Lexeo Therapeutics
LXEO
$363M
| $1.91M | 0.35% |
192,550
+194
| +0.1% | +$1.77K |
|
34
Stoke Therapeutics
STOK
$1.81B
| $1.75M | 0.32% |
+55,000
| New | +$1.65M |
|
35
MeiraGTx Holdings
MGTX
$1.15B
| $1.59M | 0.29% |
200,000
+37,000
| +23% | +$308K |
|
36
4D Molecular Therapeutics
FDMT
$612M
| $1.57M | 0.29% |
210,000
+12,542
| +6% | +$127K |
|
37
SLB Ltd
SLB
$71.1B
| $1.49M | 0.27% |
38,805
+19,108
| +97% | +$693K |
|
38
Moderna
MRNA
$26.8B
| $1.46M | 0.27% |
49,594
+2,594
| +6% | +$70.5K |
|
39
Hims & Hers Health
HIMS
$8.14B
| $1.3M | 0.24% |
40,000
| – | – |
|
40
Cartesian Therapeutics
RNAC
$253M
| $1.24M | 0.23% |
+172,500
| New | +$1.39M |
|
|
VZLA
41
Vizsla Silver
VZLA
$1.12B
| $1.12M | 0.21% |
204,654
| – | – |
|
42
Pfizer
PFE
$138B
| $940K | 0.17% |
37,750
| – | – |
|
43
Sarepta Therapeutics
SRPT
$1.9B
| $925K | 0.17% |
+43,000
| New | +$906K |
|
44
Taysha Gene Therapies
TSHA
$1.64B
| $907K | 0.17% |
164,900
+30,000
| +22% | +$146K |
|
45
NOV
NOV
$6.93B
| $830K | 0.15% |
53,126
-10,750
| -17% | -$159K |
|
|
SA
46
Seabridge Gold
SA
$2.78B
| $703K | 0.13% |
23,756
-24,718
| -51% | -$650K |
|
|
AUTL
47
Autolus Therapeutics
AUTL
$386M
| $649K | 0.12% |
326,245
+17,408
| +6% | +$26.7K |
|
48
Rocket Pharmaceuticals
RCKT
$397M
| $597K | 0.11% |
170,146
-262,614
| -61% | -$899K |
|
49
Transocean
RIG
$5.88B
| $577K | 0.11% |
139,604
+37,604
| +37% | +$146K |
|
50
SandRidge Energy
SD
$506M
| $560K | 0.1% |
38,792
-11,600
| -23% | -$153K |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM